Italia markets closed

CV Sciences, Inc. (0HRT.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0406-0,0005 (-1,22%)
Alla chiusura: 02:38PM BST
Schermo intero
Chiusura precedente0,0406
Aperto0,0442
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno0,0406 - 0,0442
Intervallo di 52 settimane0,0406 - 0,0442
Volume20.565
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)1,09
Rapporto PE (ttm)N/D
EPS (ttm)-0,1330
Prossima data utili15 ago 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    CV Sciences, Inc. Reports First Quarter 2022 Financial Results

    SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the quarter ended March 31, 2022. First Quarter 2022 and Recent Financial and Operating Highlights Revenue of $4.4 million for first quarter of 2022, compared to $4.8 million for the first quarter of 2021;Gross margin of 26.0% for first quarter of 2022, c

  • GlobeNewswire

    CV Sciences, Inc. to Announce First Quarter 2022 Results On May 16, 2022

    SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial results for the first quarter ended March 31, 2022, before the stock market opens on Monday, May 16, 2022. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) that same day. The we

  • GlobeNewswire

    CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results

    SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the year ended December 31, 2021. Fiscal 2021 and Recent Financial and Operating Highlights Revenue of $20.0 million for fiscal year 2021, compared to $24.4 million for 2020;Gross margin of 43.0% for fiscal year 2021, compared to 45.1% for 2020;Total ca